Requinate

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameRequinate
Drug Alias NameFactor VIII gene therapy (Oxford BioMedica)LentiVector-based gene therapy (Oxford BioMedica)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy
Mechanisms of ActionCoagulation factor VIII modulators
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford Biomedica PLC
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A